Literature DB >> 1708628

[Demonstration of activated oncogenes of the ras family in human thyroid tumors using the polymerase chain reaction].

B Dockhorn-Dworniczak1, S Caspari, S Schröder, W Böcker, B Dworniczak.   

Abstract

Activation of ras-oncogenes in 180 different thyroid tumours, was examined by using polymerase chain reaction (PCR) amplification and subsequent analysis of the amplification products by oligonucleotide probing, direct sequence analysis of single stranded DNA and primer-mismatch analysis. In contrast to recently published results we found a very low frequency of activated ras-genes occurring mainly in undifferentiated carcinomas and follicle cell carcinomas which show a transition to undifferentiation. In none of thirty benign tumors an activated ras-gene was found. The predominant ras-oncogene activated in thyroid neoplasias was the Harvey-ras gene. Our results suggest Harvey-ras activation at a later evolutionary step in tumour genesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1708628

Source DB:  PubMed          Journal:  Verh Dtsch Ges Pathol        ISSN: 0070-4113


  2 in total

1.  Identification of a novel HRAS variant and its association with papillary thyroid carcinoma.

Authors:  Rui Dou; Lili Zhang; Tingxia Lu; Dong Liu; Fang Mei; Jian Huang; Linxue Qian
Journal:  Oncol Lett       Date:  2018-01-17       Impact factor: 2.967

2.  Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).

Authors:  Mosin S Khan; Arshad A Pandith; Mahboob Ul Hussain; Mohammad Iqbal; Nighat P Khan; Khurshid A Wani; Shariq R Masoodi; Syed Mudassar
Journal:  Tumour Biol       Date:  2012-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.